FDA Drug Application (021748) for GLUMETZA by SANTARUS INC

Back to FDA Applications sponsored by SANTARUS INC

Application Number021748
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB3 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameGLUMETZA
Active IngredientMETFORMIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32


Back to FDA Applications sponsored by SANTARUS INC